Related by context. All words. (Click for frequent words.) 70 Epigenomics proprietary 67 LungAlert TM 66 Initiates Clinical Trial 65 mSEPT9 64 Receives Orphan Drug Designation 64 NASDAQ DIGE 64 Septin9 biomarker 63 Initiates Enrollment 63 include ColorectAlert TM 63 Septin9 63 Completes Patient Enrollment 63 Therapeutic Competitors Report 63 PF # [002] 63 deCODE ProstateCancer TM 62 oncolytic virus therapies 62 Initiates Phase II 62 visit www.genenews.com 62 ChemGenex Pharmaceuticals Limited 62 Files IND 62 Receives Orphan Drug 61 Infectious Disease Testing 61 ThermoDox ® clinical 61 Granted Orphan Drug 61 Trastuzumab DM1 61 Combination REOLYSIN R 61 COLAZAL R 61 Peginterferon alfa 2b 61 Initiates Phase III 61 Genentech sanofi aventis 61 Agendia BV 61 Namenda Memantine HCl 61 Crofelemer budesonide foam 61 mSEPT9 biomarker 61 Shows Promise Against 61 Submits NDA 61 Taiho Pharmaceutical 60 Septin 9 60 Vidaza R 60 SIX RO ROG 60 deCODE AF TM 60 Vitrasert R 60 Silodosin 60 seliciclib CYC# 60 novel emulsion formulation 60 Submits IND 60 Adjuvant Treatment 60 diabetes irritable bowel 60 commercializing Loramyc ® 60 MOVIPREP R 60 CupPrint R 60 GVAX ® 60 ovarian colon 60 Initiates Clinical 60 RPC Onko Sure 60 Amgen Neulasta ® 60 Inc Therapeutic Competitors 60 Evoltra ® 60 Onko Sure TM 60 essential thrombocythemia ET 60 Temodar ® 60 refractory chronic lymphocytic 60 pralatrexate injection folate analogue 60 Amgen Neulasta R 60 Nanobody R 60 Achieves Primary Endpoint 60 NS5b 60 Immunoassay Systems 60 Oasmia 60 Vascular Wrap TM 59 Therapeutic Competitors Companies 59 HuMax 59 R MSCRAMM 59 candidates Azedra TM 59 Therapeutic Vaccine 59 Veronate R 59 antisense inhibitors 59 Bucindolol 59 Oncotype DX ® 59 Quark Biotech 59 Vectibix panitumumab 59 topically applied SEPA 59 Analytical Tool 59 Immunotherapeutic 59 Drug Shows Promise 59 Presents Preclinical Data 59 Febuxostat 59 AviaraDx 59 BioSante Pharmaceuticals Announces 59 PARP Inhibitor 59 Fludara ® 59 Loramyc ™ 59 molecular diagnostic assay 59 DNA methylation biomarkers 59 Oxytrol R 59 Therapeutic Competitors 59 Receives Positive Opinion 59 FOLOTYN ® 59 Bevacizumab Avastin 59 Bazedoxifene 59 miRview meso 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 Prolongs Survival 59 Announces Poster Presentations 59 Gets FDA Clearance 59 SPL# Gel vaginal microbicide 59 Drug Candidate 59 Drug Fails 59 Psoriasis Drug 59 bladder ovarian 59 kidney urologic 59 Septin 9 biomarker 59 Catalyst Biosciences 59 Test Detects 59 GW# [003] 59 Chipscreen 59 LymphoStat B belimumab 59 Initiate Clinical Trial 58 OncoVex 58 OncoMethylome 58 developing Zerenex ferric 58 IMiDs ® compound 58 Licenses Novel 58 Receives Approvable Letter 58 Exploit collaboration 58 tubulin inhibitor 58 Pharma Merck Serono 58 selective estrogen receptor modulator 58 Monoclonal antibody 58 Hepatocellular 58 R sorafenib tablets 58 miRview TM 58 Zolpimist ™ 58 Demonstrates Significant 58 Xanthus Pharmaceuticals Inc. 58 PANVAC VF 58 Announces FDA Clearance 58 Astex Therapeutics Limited 58 Receives Milestone Payment 58 OncoMethylome Sciences 58 Announce License Agreement 58 ® bortezomib 58 epoetin zeta 58 Kiadis 58 Multiple Sclerosis Rheumatoid Arthritis 58 HER2 Positive 58 dyslipidemia hypertension diabetes 58 Hedgehog Pathway Inhibitor 58 Announce Collaboration Agreement 58 immunotherapeutic vaccine 58 PHRM 58 Aflibercept 58 acyclovir Lauriad R 58 cardio renal 58 nilotinib Tasigna 58 Submits Biologics License Application 58 rheumatoid arthritis Roche PEGASYS 58 Antisense Pharma GmbH 58 IMiDs ® 58 Reports Preclinical Data 58 Receives Marketing Authorization 58 Xeloda ® 58 INSPIRE Trial Phase III 58 Teva Provides Update 58 non nucleoside inhibitor 58 IMiDs R 57 Aplidin 57 www.bio rad.com 57 OTC BB PVCT 57 SinuNase ™ 57 Multiple Ascending Dose 57 Neulasta R 57 Soft Tissue Sarcoma 57 MKC# MKC# PP 57 Phase III multicenter 57 Inc. www.micromet inc.com 57 NeutroSpec TM 57 oropharyngeal candidiasis OPC 57 initiated Phase Ib 57 metastatic malignant 57 PTK# 57 Copegus ® 57 Rheumatoid Arthritis Drug 57 acetonide FA 57 receptor tyrosine kinase inhibitor 57 Aloxi ® 57 ovarian pancreatic 57 Hormone Refractory Prostate Cancer 57 Shows Efficacy 57 Diagnostic Tests 57 FDA Clears 57 Tibotec BVBA 57 Begins Dosing 57 novel therapeutic antibodies 57 Nucleic Acid Detection Immunoassay 57 RhuDex TM 57 Extends Collaboration 57 Nereus Pharmaceuticals 57 DIRECT Trial 57 Ltd Therapeutic Competitors 57 GlaxoSmithKline MedImmune 57 Asthma COPD 57 Amira Pharmaceuticals 57 personalized dendritic 57 Generx ® 57 Xcytrin R 57 CNS Disorders 57 ALN HPN 57 JAK2 Inhibitor 57 Tesmilifene 57 proprietary radiolabeled monoclonal 57 Abstract Accepted 57 sapacitabine CYC# 57 Successfully Completes Phase 57 Bayer HealthCare Onyx Pharmaceuticals 57 advanced hepatocellular carcinoma 57 Alfacell proprietary ribonuclease 57 Completes Dosing 57 fluorinated carbohydrate mimics 57 pharmacogenomic translational research 57 HIV integrase inhibitor 57 HepaSphere 57 Demonstrates Sustained 57 Presents Positive 57 BRAF mutant 57 Viread tenofovir disoproxil fumarate 57 MSCRAMM ® 57 Aptamer 57 tests miRview TM 57 MEDAREX 57 Covalys 57 Patients Treated With 57 Akesis Pharmaceuticals 57 Announce Licensing Agreement 57 Initiates Phase 2b 57 QIAGEN Nasdaq QGEN 57 Fresenius Biotech 57 palonosetron hydrochloride Injection Dacogen 57 pregnancy bacterial vaginosis 57 Genotyping Test 57 Cancer Incidence Mortality 57 Deforolimus 57 Intendis 57 Becton Dickinson BD 57 hc2 High Risk 57 Announces Tentative Approval 57 BRILINTA 57 resistant hormone refractory 56 immatics 56 androgen receptor antagonist 56 Bayhill Therapeutics 56 Actimmune ® 56 Crucell NV NYSE Euronext 56 Temsirolimus 56 Vernalis plc 56 Vaccine Adjuvant 56 Systemic Delivery 56 Investigational Compound 56 recurrent metastatic 56 follicular Non Hodgkin 56 VivaGel ™ 56 Meets Primary Endpoint 56 MammaPrint R 56 FDA APPROVES 56 Adenuric R 56 Maven Semantic 56 Hepatocellular Carcinoma 56 SUTENT ® 56 Invasive pneumococcal disease 56 Safinamide 56 Kinase Inhibitor 56 NuroPro PD 56 Nasdaq CRXL 56 platform HDL Mimetic 56 induced mucositis 56 deCODE BreastCancer 56 novel oral anticoagulant 56 TKPHF 56 cervical prostate 56 VeriStrat 56 CYT# potent vascular disrupting 56 Oxford Immunotec 56 Oral Suspension USP 56 AUDIO PROVIDED BY 56 Submits Response 56 Preclinical Models 56 Completes Enrollment 56 OPi 56 IG HCR ;) CO 56 Gedeon Richter Plc 56 NASH Huntington 56 gets USFDA nod 56 Sanofi Aventis Taxotere 56 Postmenopausal hormone therapy 56 QuickVue R 56 Pertuzumab 56 RELOVAIR ™ 56 ErbB2 positive 56 lexidronam injection 56 EMD Biosciences 56 SuperAntibody 56 TheraScreen 56 Vytorin combines 56 Recombinant Human 56 Alferon LDO 56 HDAC Inhibitor 56 AdVac 56 Signature Diagnostics 56 EMD Biosciences Inc. 56 gefitinib Iressa 56 thalidomide Thalomid 56 Esmya 56 miconazole Lauriad ® 56 Lung Cancer Drug 56 FirstCyte 56 Prospective Randomized 56 PhotoPoint R 56 ASX PGL 56 Epirubicin 56 BC SeraPro ™ 56 Pharmacogenomic 56 INTERNATIONAL HOLDINGS INC. 56 related CMV Retinitis 56 www.mivtherapeutics.com 56 Adenoscan R 56 NS5B polymerase 56 Novel Inhibitor 56 APTIMA R 56 Visit www.BASInc.com 56 LymphoStat B TM 56 Presents Preclinical 56 Orally Active 56 NPM1 56 Launches Generic Version 56 Takeda Pharma 56 radiation sensitizer 56 Submits Supplemental 56 Kinase Inhibitors 56 KYTHERA Biopharmaceuticals Inc. 56 Nasdaq ONXX 56 Angiotensin Converting Enzyme 56 Luveris R Ovidrel R 56 Antitumor Activity 56 Nasdaq ACHN 56 Cardiotoxicity 56 Founding Scientist 56 Trandolapril 55 accumulate preferentially 55 Initiates Dosing 55 ESTRASORB ® 55 MD Moross Institute 55 CYCLOSET ® 55 Randomized Study 55 Receives Fast Track 55 Squamous 55 Anticancer Drug 55 Preclinical Study 55 Pulmo BioTech Inc. 55 Cytoxan ® 55 CAMPATH 55 ProtAffin 55 gastrointestinal stromal tumors GISTs 55 Idera Pharmaceuticals 55 Prevalence Worldwide 55 AFREZZA TM 55 PharmaVitae Profile 55 Protease Inhibitor 55 Biomarker Study 55 Finacea 55 RhuDex ® 55 interferon gamma 1b 55 Vaccine Protects Against 55 Pazopanib 55 AdnaGen AG 55 Xelox 55 Pfizer Camptosar 55 Auxilium Pharma 55 Naive Patients 55 psoriasis rheumatoid arthritis 55 Panzem ® 55 Awarded Qualifying Therapeutic 55 Postdoctoral Position 55 R lenalidomide 55 HCV genotyping 55 COPEGUS R 55 Basilea Toctino R 55 Demonstrates Potential 55 Omacor ® 55 SynCo Bio Partners 55 InSure FIT 55 SmarTrend Diagnostic Substances 55 finasteride Proscar 55 Targeted Therapies 55 Identifies Potential 55 PREVU x LT 55 ONCASPAR 55 Receive Milestone Payment 55 NorDiag 55 Fujisawa Healthcare Inc. 55 OvaDx 55 rxRNA 55 Copegus R 55 Liprotamase 55 Gnant consults 55 Small Molecule 55 FDA Accepts 55 Affimed Therapeutics AG 55 TRANSDUR ® 55 OPAXIO TM 55 SPRYCEL ® 55 Enrolls First 55 superparamagnetic iron oxide nanoparticles 55 rheumatoid arthritis inflammatory bowel 55 HER2 Positive Breast Cancer 55 Pafuramidine 55 RhuDex R 55 Takeda Kyowa Hakko Kirin 55 Enterix 55 Skin Cholesterol Test 55 molecular diagnostic assays 55 include Alferon N 55 Inotek Pharmaceuticals Corporation 55 Wyeth Enbrel 55 TFChem licenses 55 ASGCT 55 Awarded Patents 55 Zorbtive TM 55 controlled multicenter Phase 55 Organon Pharmaceuticals 55 nonmetastatic 55 Nipent R 55 Lymphoid 55 glucokinase activator 55 Oncotype 55 www.ucb.com 55 demonstrated antitumor activity 55 Anti Tumor Activity 55 Cancer Vaccines 55 Ad5FGF 4 55 VALSTAR TM 55 TOPICA 55 Develop Novel 55 Plavix clopidogrel bisulfate 55 M.D. Ph.D. 55 Gleevec imatinib mesylate 55 PROLARIS 55 Transdermal Patch 55 MERREM 55 phase IIIb 55 FDA Okays 55 oral beclomethasone dipropionate 55 cyclophilin inhibitors 55 Geodon ziprasidone 55 Vitrasert ® 55 Small Molecules 55 etanercept Enbrel 55 Vitro Activity 55 Alnylam Pharmaceuticals Nasdaq ALNY 55 Begins Clinical Trial 55 PRN FDA Approves 55 Patent Covering 55 TBlue 55 Novel Therapeutic 54 R Saizen R 54 Illumina GoldenGate 54 Severe Sepsis 54 hyaluronidase enzyme 54 HCV Protease Inhibitor 54 Stakeholder Opinions 54 Interferon alfa 54 Xeloda capecitabine 54 Previously Untreated 54 Receives Tentative Approval 54 DXL ™ 54 Darinaparsin 54 Co Receptor Tropism 54 oncologic diseases 54 Femring ® 54 Vaxfectin formulated 54 Salmonella Shigella 54 Interferon Alpha 54 investigational immunotherapy 54 NASDAQ DCGN 54 Quark Pharmaceuticals 54 Momenta Pharmaceuticals MNTA 54 Pegloticase 54 Inovio Pharmaceuticals 54 myelodysplastic myeloproliferative diseases 54 number NCT# ClinicalTrials.gov 54 Anti Tumor 54 Bacteremia 54 HIV Integrase 54 Evoltra 54 Cellular Immunology 54 tadenovec Ad5FGF 4 54 trade name Normix 54 multicenter Phase II 54 Cerenis Therapeutics 54 Present Preclinical Data 54 Levitronix LLC 54 BRAHMS AG 54 outlicensed 54 Inflammatory Disease 54 Prognostic Value 54 Zygogen 54 Lupus Drug 54 Stromedix 54 Collaborators Publish 54 Commercialize Novel 54 Tumor Marker 54 gastro intestinal inflammation 54 Glatiramer Acetate 54 candidates Dyloject TM 54 Boehringer Ingleheim 54 Antigen CEA 54 HuMax CD#b 54 exclusive sublicense 54 TolerRx 54 Malignant Melanoma 54 Metabolic Endocrinology 54 thiazolides 54 UroVysion 54 Calcium Acetate 54 Imatinib mesylate 54 please visit www.abraxane.com 54 NASDAQ CPHD 54 vitro diagnostics IVD 54 Kosan dependence 54 Glycosylation 54 Presents Positive Preclinical 54 RECOTHROM R 54 HPV cervical dysplasia 54 please visit http:/www.atherogenics.com 54 MagForce Nanotechnologies AG 54 vapreotide acetate 54 Xoma Ltd 54 GENASIS 54 Apitope 54 Aryplase 54 NMP# 54 Mutation Detection 54 Leukine ® 54 Sign License Agreement 54 Alexion Soliris 54 PEGylated interferon 54 EGS# 54 Shows Promising 54 ovarian breast 54 Cholesterol Lowering Drug 54 HELSINN 54 Oral Insulin 54 Desvenlafaxine 54 HX Diagnostics 54 Nitec Pharma 54 NPS Pharma 54 Alkeran 54 Improves Outcomes 54 chimeric monoclonal antibody 54 tramiprosate Alzhemed TM 54 Roche Boniva 54 Cathepsin S 54 www.appliedneurosolutions.com 54 M# rationally 54 migraine headaches neuropathic pain 54 Benicar HCT 54 markets COLAZAL 54 orally inhaled migraine 54 Prolexys 54 Atopic Dermatitis 54 cosmetic cosmeceutical products 54 BAYRY 54 Panzem R NCD 54 Therapy Improves 54 Alnylam ALNY 54 PDE4 inhibitor 54 Entry Inhibitor 54 Improves Survival 54 Velcade bortezomib 54 XIENCE V drug eluting 54 LHRH receptor positive 54 Pharmaceuticals Initiates 54 Tumor Targeting 54 Warfarin Coumadin 54 Inc. Nasdaq AMGN 54 papillary renal cell carcinoma 54 Anti Infective 54 VentiRx Pharmaceuticals 54 T1c 54 #:#-# [006] 54 Enzon Pharmaceuticals Inc 54 BellBrook Labs 54 See CLINICAL PHARMACOLOGY 54 relapsed MM 54 Partnering Agreements 54 vitro pharmacology 54 tumor xenograft models 54 Pharmacueticals 54 Nexavar prescribing 54 Novartis NVS Snapshot Report 54 Pharmacokinetics PK 54 Pepscan Therapeutics 54 BreastCancer 54 Investigational Treatment 54 Santhera Pharmaceuticals 54 CYP#A# CYP#D# 54 OvaRex R 54 Fulvestrant 54 Xytis 54 Newron Pharmaceuticals SpA 54 Molecular Diagnostic 54 please visit http:/www.vandapharma.com 54 Idenix Pharmaceuticals 53 e antigen HBeAg 53 antimitotic 53 Nasdaq IDIX 53 Therapy Shows Promise 53 DAPT Study 53 Sebivo 53 antibody MAb 53 endothelin antagonist 53 Small Molecule Drug 53 ProFibrix 53 Parathyroid Hormone 53 Pathway Diagnostics 53 NASDAQ OMER 53 Proteo 53 Migraine Drug 53 Celera CRA 53 Metabolic Disease 53 Marqibo TM 53 ZARS Pharma 53 Medicis Pharmaceutical Corp 53 Therapeutic Targets 53 include ClindaReach TM 53 NMP# R 53 Moxifloxacin 53 PREVU i 53 Adenoviral 53 rheumatoid arthritis psoriatic arthritis 53 Integra Lifesciences 53 please visit http:/www.sunesis.com 53 Advanced Melanoma 53 ara C 53 staphylococcal vaccine 53 PREVU * LT 53 Anticancer Agent 53 Sanvar 53 Nitazoxanide 53 Degarelix 53 Pemetrexed 53 DNAwithPap TM Test 53 Nilotinib 53 balsalazide disodium Capsules 53 Zevtera ™ 53 NICE Recommends 53 Kiadis Pharma 53 DF HCC 53 Adjuvant Chemotherapy 53 Amplicor 53 Polymerase Inhibitor 53 HBV HCV 53 HCV polymerase 53 proteasome inhibitor 53 Olmesartan 53 Biomarin 53 vinorelbine tartrate 53 Combivir Kivexa 53 pan HDAC inhibitor 53 midstage clinical 53 NYSE PFE Exelon Rivastigmine 53 Allergan NYSE AGN 53 humanized monoclonal 53 Leukemias 53 Gastrointestinal Stromal Tumors 53 Diatos 53 ORIDIS Biomed 53 HyACT 53 MedPulser 53 Ridaforolimus 53 Frozen Shoulder syndrome 53 G#DT 53 Torisel temsirolimus 53 Treatment Shows Promise 53 Oncology Compounds 53 plasma protein biotherapeutics 53 TRIOLEX HE# APOPTONE HE# 53 Ambion Diagnostics 53 Clinical Trial Data 53 Epidermal Growth Factor Receptor 53 Muraglitazar 53 Nasdaq IMMU 53 IL# PE#QQR 53 Boxed Warnings 53 Bacterin develops manufactures 53 equine osteoarthritis marketed 53 Reata Pharmaceuticals 53 Tibotec Pharmaceuticals Ltd. 53 Veregen 53 adenosine injection 53 Cancer Res 53 Mg Uk 53 HemoGenix 53 Nextech Venture 53 dutogliptin 53 Merck Serono Nycomed 53 Abbott Molecular 53 III EGFRvIII 53 Risk Stratification 53 Zelos Therapeutics 53 Generic Versions 53 AxSYM 53 Osteoporosis Drug 53 Monoclonal Antibodies 53 Ovarian Cancers 53 Protease Inhibitors 53 Assay Kits 53 FullTerm 53 www.cmdiagnostics.com 53 AMDL DR 53 LAB CGRP 53 visit http:/www.PAREXEL.com 53 Merz Pharmaceuticals 53 LUNESTA ® 53 neuropathic pain metabolic diseases 53 Ascenta Therapeutics 53 Associated Diarrhea 53 Hepatitis C Virus 53 quantitative cytology 53 proprietary intravenous formulation 53 MolecularMD 53 albiglutide 53 Anticalin R 53 Saladax Biomedical 53 Rebif ® 53 Targeted Therapy 53 Vidaza ® 53 Astex Therapeutics 53 Progenics Pharmaceuticals 53 Protein Expression 53 Afferent Pharmaceuticals 53 Antisense Pharma 53 Reveals Positive 53 AnaSpec Introduces 53 Aurora Kinase 53 Bosutinib 53 mtm laboratories 53 Sanofi aventis NYSE SNY 53 Elagolix 53 indinavir Crixivan 53 Diasome 53 Nasdaq IPXL 53 Library HuCAL 53 PHARMACEUTICALS INC 53 Chemotherapeutic Agents 53 biobetter 53 Antiviral Therapy 53 Decision Biomarkers 53 include Healive 53 Preclinical Development 53 HCV Hepatitis C 53 SBL Vaccines 53 Scil 53 Synvisc ONE 53 Sipuleucel T 53 Therapeutic Antibody 53 BioPartners 53 Orazol 53 Oral Fluid 53 OVIT 53 Marinomed 53 Gemzar gemcitabine 53 Vivecon 53 Millenium Pharmaceuticals 53 AMEX KAL 53 PROCLEIX R 53 Boehringer Ingelheim MedImmune 53 anti CD# antibodies 53 Irinotecan 53 Announce Initiation 53 multigene expression test 53 paclitaxel Taxol ® 53 visit http:/www.martek.com 53 ACE BioSciences 53 Benign Prostatic Hyperplasia 53 CCR5 receptor antagonist 53 Norgine BV 53 Enbrel etanercept 53 Novartis Organon 53 isoform selective 53 Vascular Biogenics 53 NV Organon 53 Correlogic 53 immunohistochemical 52 Vaccine Shows Promise 52 Susceptibility Testing 52 chemotherapy cisplatin 52 anticancer antiviral 52 Aegerion Pharmaceuticals Inc. 52 Respiratory Disorders 52 Ganciclovir 52 Cloretazine VNP#M 52 molecular biology reagents 52 SYN X 52 Eraxis 52 KAI Pharmaceuticals 52 Agios Pharmaceuticals 52 Monoclonal 52 Protein Biomarker 52 Paclitaxel Carboplatin 52 markets HP Acthar 52 Cancidas 52 Transdermal Delivery 52 Clinical Outcome 52 AzaSite TM 52 Alexza Pharma 52 fusion enhancers 52 unresectable inoperable 52 Topiramate Tablets 52 Ultrasensitive 52 cisplatin gemcitabine 52 Tyrosine Kinase Inhibitor 52 Onconase 52 Bristol Myers Squibb Pravachol 52 metastatic neuroendocrine tumors 52 IDI MRSA 52 Solorel ® 52 Capsulution 52 RH1 52 Polymorphisms 52 cisplatin carboplatin 52 MEK Inhibitor 52 Vitro Diagnostic IVD 52 Anticancer Drugs 52 molecular biology genomics 52 Disease IBD 52 Avidex 52 G CSFs 52 Epratuzumab 52 Immune Therapy 52 Ambrisentan 52 Levoleucovorin 52 nucleoside analog 52 Genentech Roche Chugai 52 zoledronic acid Zometa 52 TomTec Imaging Systems 52 Kevetrin ™ 52 PathFinderTG 52 PC Detect SM 52 Immunotherapies 52 Avonex interferon beta 1a 52 Zosano Pharma 52 HER2 ErbB2 52 PROTONIX 52 ZFNs clinical trials 52 PRAVACHOL R 52 Demonstrates Positive 52 peptide conjugated 52 Isis Pharma 52 Receives Complete Response 52 Vaxfectin R formulated 52 Immunoassays 52 Brain Metastases 52 ® adefovir dipivoxil 52 Camptosar ® 52 Immunicon dependence 52 Novel Therapies 52 Scientific Advisory Boards 52 Respiratory Viral Panel 52 trastuzumab emtansine T DM1 52 Sycrest 52 Cervista HPV HR 52 Sankyo Pharma 52 Zybrestat 52 Medisorb ® 52 Pink Sheets RHHBY 52 Genentech Rituxan 52 AdnaTest 52 Angiolix 52 Hepatic Encephalopathy 52 Myocardial Perfusion Imaging 52 neurology immunology 52 MVA BN R 52 Hepatitis C HCV 52 Allogeneic 52 FDA Approvals 52 rhLF 52 urology oncology 52 star.edu.sg 52 Therapeutic Antibodies 52 CNS Therapeutics 52 Beerse Belgium 52 HER1 52 p# biomarker 52 immunotherapeutic approaches 52 oral renin inhibitor 52 Fluorouracil 52 topical gel containing 52 IV Busulfex 52 virosome 52 miRNA biomarkers 52 Successfully Treats 52 Anti infective 52 acid phosphatase PAP 52 multicenter Phase III 52 Drug Resistant 52 Alferon N 52 Nivestim 52 Toxicogenomics 52 AB OMXS BINV 52 PLAVIX ® 52 DCVax R 52 Multicenter Phase 52 Genentech Wyeth Pharmaceuticals 52 Demonstrates Efficacy 52 Plaquenil 52 Sapacitabine 52 INxin TM 52 Tipranavir 52 OSMOPREP TM 52 Seattle Genetics SGEN 52 Integromics 52 Immuron 52 hepatitis C HCV 52 Jean François Labbé 52 Cypher Sirolimus 52 investigational integrase inhibitor 52 Bionate ® PCU 52 ophthalmics 52 Sustiva efavirenz 52 JAK inhibitor 52 FUSILEV enhances 52 DepoCyt 52 Papillary 52 Arthritis Drug 52 combines bupropion 52 co receptor tropism 52 dasatinib Sprycel 52 developing Surfactant Replacement 52 preclinical efficacy 52 castration resistant hormone refractory 52 Atelvia 52 Sirolimus eluting 52 www.siemens.com healthcare 52 Vitaxin 52 Selzentry Celsentri 52 Posaconazole 52 Delafloxacin 52 Betaferon R 52 Leica Microsystems IR 52 Actelion Pharmaceuticals Ltd 52 hypervascular tumors 52 SmPC 52 Bristol Myers Squibb Sprycel 52 targeting Inflammatory Bowel 52 Januvia sitagliptin 52 Boehringer Ingelheim Bristol Myers 52 ZETIA ezetimibe 52 RGEN 52 Vysis 52 NSABP B 52 GenPath 52 MiraCare TM 52 Adlyfe 52 PCA3 gene 52 Source MDx 52 Endometrial 52 ILLUSTRATE 52 NASDAQ ONXX 52 NADiA 52 ® lenalidomide 52 Vidaza azacitidine 52 plerixafor 52 CALGB 52 ergot derivatives 52 Polyphor 52 V3D Colon 52 endocrinology gastroenterology 52 Rotavirus Vaccine 52 PENNVAX ™ B 52 Neovastat 52 multicenter multinational 52 Cellular Therapies 52 Surface Plasmon Resonance SPR 52 Pierre Fabre SA 52 PRESEPT study 52 Biomax Informatics AG 52 Diovan Exforge Tekturna Zelnorm 52 Nasdaq IDRA today 52 Traversa Therapeutics 52 Gendux 52 Myriad Genetics Inc 52 Omnitarg 52 CureDM 52 CardioVascular BioTherapeutics 52 plasmid DNA pDNA 52 pancreatic lung 52 Dealmaking Profile 52 Preclinical Data 52 Xenografts 52 Oral Cladribine